Search results
Results from the WOW.Com Content Network
Drug repositioning is a "universal strategy" for neglected diseases due to 1) reduced number of required clinical trial steps could reduce the time and costs for the medicine to reach market, 2) existing pharmaceutical supply chains could facilitate "formulation and distribution" of the drug, 3) known possibility of combining with other drugs ...
Walgreens Completes Acquisition of USA Drug Pharmacy Chain DEERFIELD, Ill.--(BUSINESS WIRE)-- Walgreen Co. (NYS: WAG) (NAS: WAG) announced today that it has completed its purchase of a regional ...
Acquisition: 111.8: 204 [2] 2: ... in order to maintain control of the blockbuster drug - Lipitor. [20 ... refocusing on its five-year plan to double earnings and ...
"Acquisition" usually refers to a purchase of a smaller firm by a larger one. Sometimes, however, a smaller firm will acquire management control of a larger and/or longer-established company and retain the name of the latter for the post-acquisition combined entity. This is known as a reverse takeover.
Most Part D plans cover the costs of generic and brand-name prescription drugs. There is a formulary, or list of medications, and each plan must cover at least two drugs in the “most commonly ...
Selecting a Part D prescription drug plan is one of the hardest Medicare decisions because there are so many factors to consider: the medications you take; where to buy them; the cost of Part D ...
Glaser Drug Company sold its Express Scripts partnership interest back to Sanus before it was acquired by chain SupeRx in 1989 for $18.2 million. SupeRX declared bankruptcy and all stores closed in 1991 after Walgreens acquired the pharmacy records. SupeRX's loan to buy Glaser Drug Co. had been financed by Lincoln Savings and Loan Association ...
The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. [3] Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. [4]